综述

iPS细胞的遗传安全性

展开
  • 中国科学技术大学生命科学学院, 合肥微尺度物质科学国家实验室, 合肥 230027

收稿日期: 2011-11-16

  修回日期: 2012-01-12

  网络出版日期: 2012-03-25

基金资助

中国科学院“百人计划”项目(编号:KJ207004)和国家自然科学基金项目(编号:30711120571)资助

The genetic safety of induced pluripotent stem (iPS) cells

Expand
  • Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, University of Science and Technology of China, Hefei 230027, China

Received date: 2011-11-16

  Revised date: 2012-01-12

  Online published: 2012-03-25

摘要

自2006年Takahashi和Yamanaka首次成功地从小鼠成纤维细胞诱导得到诱导多能性干细胞(Induced pluripotent stem cells, iPS细胞)以来, iPS细胞由于其潜在的广阔应用前景而迅速成为干细胞研究领域的新热点; 与此同时, iPS细胞的遗传安全性也越来越多地受到人们的关注。文章将对iPS细胞遗传安全性的研究进展进行综述, 分析造成iPS细胞遗传不稳定的可能原因, 希望可以促进对iPS细胞诱导条件的优化, 获得遗传上较为安全的iPS细胞。

本文引用格式

陈倩,史庆华 . iPS细胞的遗传安全性[J]. 遗传, 2012 , 34(3) : 260 -268 . DOI: 10.3724/SP.J.1005.2012.00260

Abstract

Since Takahashi and Yamanaka first generated induced pluripotent stem (iPS) cells from mouse fibroblasts successfully in 2006, iPS cells have rapidly become a new hotspot in the field of stem cells research because of their broad potential application prospects. Meanwhile, more and more attentions are paid to the genetic safety of iPS cells. This article summarizes recent findings on genetic safety of iPS cells and reviews the possible causes leading to genetic instability of iPS cells. Hopefully, this review is helpful to improve the induction of iPS cells and obtain genetically safe iPS cells.

参考文献

[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676.
[2] Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol, 2006, 18(6): 658-667.
[3] Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. 2007. http://cgapncinihgov/ Chromosomes/Mitelman.
[4] Yu JY, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bour-get J, Frane JL, Tian SL, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318(5858): 1917-1920.
[5] Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell, 2007, 1(3): 245-247.
[6] Park IH, Zhao R, West JA, Yabuuchi A, Huo HG, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008, 451(7175): 141-146.
[7] Li CL, Yu HY, Ma Y, Shi GL, Jiang J, Gu JJ, Yang Y, Jin SB, Wei Z, Jiang H, Li JS, Jin Y. Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One, 2009, 4(8): e6724.
[8] Yu JY, Hu KJ, Smuga-Otto K, Tian SL, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009, 324(5928): 797-801.
[9] Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA, 2009, 106(1): 157-162.
[10] Li WL, Wei W, Zhu SY, Zhu JL, Shi Y, Lin TX, Hao EG, Hayek A, Deng HK, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 2009, 4(1): 16-19.
[11] Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009, 4(6): 472-476.
[12] Cho HJ, Lee CS, Kwon YW, Paek JS, Lee SH, Hur J, Lee EJ, Roh TY, Chu IS, Leem SH, Kim Y, Kang HJ, Park YB, Kim HS. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood, 2010, 116(3): 386-395.
[13] Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vi-tro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 2007, 448(7151): 318-324.
[14] Mali P, Ye ZH, Hommond HH, Yu XB, Lin J, Chen GB, Zou JZ, Cheng LZ. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells, 2008, 26(8): 1998- 2005.
[15] Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322(5903): 945-949.
[16] Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell, 2010, 7(4): 521-531.
[17] Minina IuM, Zhdanova NS, Shilov AG, Tolkunova EN, Liskovykh MA, Tomilin AN. Chromosomal instability of in vitro cultured mouse embryonic stem cells and induced pluripotent stem cells. Tsitologiia, 2010, 52(5): 420-425.
[18] Sommer CA, Sommer AG, Longmire TA, Christodoulou C, Thomas DD, Gostissa M, Alt FW, Murphy GJ, Kotton DN, Mostoslavsky G. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells, 20
文章导航

/